SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K12B

8-K12B

Other
View HTML
424B7

424B7    

Registration Statements
View HTML
424B7

424B7    

Registration Statements
View HTML
424B7

424B7    

Registration Statements
View HTML
424B7

424B7    

Registration Statements
View HTML

Data provided by Kaleidoscope.